Drug
Mvt 2163
Mvt 2163: highest development phase Phase 1, developed by BioNTech. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BioNTech
Trials
| Drug | Phase | Indication |
|---|---|---|
| MVT-2163 NCT02687230 | Phase 1 | Pancreatic Carcinoma |
Latest
No recent events.
Follow Mvt 2163 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.